Sorafenib-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Sorafenib-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Sorafenib industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Sorafenib 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Sorafenib worldwide and market share by regions, with company and product introduction, position in the Sorafenib market
Market status and development trend of Sorafenib by types and applications
Cost and profit status of Sorafenib, and marketing status
Market growth drivers and challenges
The report segments the global Sorafenib market as:
Global Sorafenib Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Sorafenib Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Capsule
Tablet
Global Sorafenib Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacy
Retail Pharmacy
Online Pharmac
Global Sorafenib Market: Manufacturers Segment Analysis (Company and Product introduction, Sorafenib Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Allergan
Alnylam Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Levolta Pharmaceuticals
Mabtech
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Sorafenib-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Sorafenib industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Sorafenib 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Sorafenib worldwide and market share by regions, with company and product introduction, position in the Sorafenib market
Market status and development trend of Sorafenib by types and applications
Cost and profit status of Sorafenib, and marketing status
Market growth drivers and challenges
The report segments the global Sorafenib market as:
Global Sorafenib Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Sorafenib Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Capsule
Tablet
Global Sorafenib Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacy
Retail Pharmacy
Online Pharmac
Global Sorafenib Market: Manufacturers Segment Analysis (Company and Product introduction, Sorafenib Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Allergan
Alnylam Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Levolta Pharmaceuticals
Mabtech
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF SORAFENIB
1.1 Definition of Sorafenib in This Report
1.2 Commercial Types of Sorafenib
1.2.1 Capsule
1.2.2 Tablet
1.3 Downstream Application of Sorafenib
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Online Pharmac
1.4 Development History of Sorafenib
1.5 Market Status and Trend of Sorafenib 2013-2023
1.5.1 Global Sorafenib Market Status and Trend 2013-2023
1.5.2 Regional Sorafenib Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Sorafenib 2013-2017
2.2 Sales Market of Sorafenib by Regions
2.2.1 Sales Volume of Sorafenib by Regions
2.2.2 Sales Value of Sorafenib by Regions
2.3 Production Market of Sorafenib by Regions
2.4 Global Market Forecast of Sorafenib 2018-2023
2.4.1 Global Market Forecast of Sorafenib 2018-2023
2.4.2 Market Forecast of Sorafenib by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Sorafenib by Types
3.2 Sales Value of Sorafenib by Types
3.3 Market Forecast of Sorafenib by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Sorafenib by Downstream Industry
4.2 Global Market Forecast of Sorafenib by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Sorafenib Market Status by Countries
5.1.1 North America Sorafenib Sales by Countries (2013-2017)
5.1.2 North America Sorafenib Revenue by Countries (2013-2017)
5.1.3 United States Sorafenib Market Status (2013-2017)
5.1.4 Canada Sorafenib Market Status (2013-2017)
5.1.5 Mexico Sorafenib Market Status (2013-2017)
5.2 North America Sorafenib Market Status by Manufacturers
5.3 North America Sorafenib Market Status by Type (2013-2017)
5.3.1 North America Sorafenib Sales by Type (2013-2017)
5.3.2 North America Sorafenib Revenue by Type (2013-2017)
5.4 North America Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Sorafenib Market Status by Countries
6.1.1 Europe Sorafenib Sales by Countries (2013-2017)
6.1.2 Europe Sorafenib Revenue by Countries (2013-2017)
6.1.3 Germany Sorafenib Market Status (2013-2017)
6.1.4 UK Sorafenib Market Status (2013-2017)
6.1.5 France Sorafenib Market Status (2013-2017)
6.1.6 Italy Sorafenib Market Status (2013-2017)
6.1.7 Russia Sorafenib Market Status (2013-2017)
6.1.8 Spain Sorafenib Market Status (2013-2017)
6.1.9 Benelux Sorafenib Market Status (2013-2017)
6.2 Europe Sorafenib Market Status by Manufacturers
6.3 Europe Sorafenib Market Status by Type (2013-2017)
6.3.1 Europe Sorafenib Sales by Type (2013-2017)
6.3.2 Europe Sorafenib Revenue by Type (2013-2017)
6.4 Europe Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Sorafenib Market Status by Countries
7.1.1 Asia Pacific Sorafenib Sales by Countries (2013-2017)
7.1.2 Asia Pacific Sorafenib Revenue by Countries (2013-2017)
7.1.3 China Sorafenib Market Status (2013-2017)
7.1.4 Japan Sorafenib Market Status (2013-2017)
7.1.5 India Sorafenib Market Status (2013-2017)
7.1.6 Southeast Asia Sorafenib Market Status (2013-2017)
7.1.7 Australia Sorafenib Market Status (2013-2017)
7.2 Asia Pacific Sorafenib Market Status by Manufacturers
7.3 Asia Pacific Sorafenib Market Status by Type (2013-2017)
7.3.1 Asia Pacific Sorafenib Sales by Type (2013-2017)
7.3.2 Asia Pacific Sorafenib Revenue by Type (2013-2017)
7.4 Asia Pacific Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Sorafenib Market Status by Countries
8.1.1 Latin America Sorafenib Sales by Countries (2013-2017)
8.1.2 Latin America Sorafenib Revenue by Countries (2013-2017)
8.1.3 Brazil Sorafenib Market Status (2013-2017)
8.1.4 Argentina Sorafenib Market Status (2013-2017)
8.1.5 Colombia Sorafenib Market Status (2013-2017)
8.2 Latin America Sorafenib Market Status by Manufacturers
8.3 Latin America Sorafenib Market Status by Type (2013-2017)
8.3.1 Latin America Sorafenib Sales by Type (2013-2017)
8.3.2 Latin America Sorafenib Revenue by Type (2013-2017)
8.4 Latin America Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Sorafenib Market Status by Countries
9.1.1 Middle East and Africa Sorafenib Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Sorafenib Revenue by Countries (2013-2017)
9.1.3 Middle East Sorafenib Market Status (2013-2017)
9.1.4 Africa Sorafenib Market Status (2013-2017)
9.2 Middle East and Africa Sorafenib Market Status by Manufacturers
9.3 Middle East and Africa Sorafenib Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Sorafenib Sales by Type (2013-2017)
9.3.2 Middle East and Africa Sorafenib Revenue by Type (2013-2017)
9.4 Middle East and Africa Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF SORAFENIB
10.1 Global Economy Situation and Trend Overview
10.2 Sorafenib Downstream Industry Situation and Trend Overview
CHAPTER 11 SORAFENIB MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Sorafenib by Major Manufacturers
11.2 Production Value of Sorafenib by Major Manufacturers
11.3 Basic Information of Sorafenib by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Sorafenib Major Manufacturer
11.3.2 Employees and Revenue Level of Sorafenib Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 SORAFENIB MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer
12.1.1 Company profile
12.1.2 Representative Sorafenib Product
12.1.3 Sorafenib Sales, Revenue, Price and Gross Margin of Pfizer
12.2 Allergan
12.2.1 Company profile
12.2.2 Representative Sorafenib Product
12.2.3 Sorafenib Sales, Revenue, Price and Gross Margin of Allergan
12.3 Alnylam Pharmaceuticals
12.3.1 Company profile
12.3.2 Representative Sorafenib Product
12.3.3 Sorafenib Sales, Revenue, Price and Gross Margin of Alnylam Pharmaceuticals
12.4 Acceleron Pharma
12.4.1 Company profile
12.4.2 Representative Sorafenib Product
12.4.3 Sorafenib Sales, Revenue, Price and Gross Margin of Acceleron Pharma
12.5 Biocon
12.5.1 Company profile
12.5.2 Representative Sorafenib Product
12.5.3 Sorafenib Sales, Revenue, Price and Gross Margin of Biocon
12.6 Bionomics
12.6.1 Company profile
12.6.2 Representative Sorafenib Product
12.6.3 Sorafenib Sales, Revenue, Price and Gross Margin of Bionomics
12.7 CASI Pharmaceuticals
12.7.1 Company profile
12.7.2 Representative Sorafenib Product
12.7.3 Sorafenib Sales, Revenue, Price and Gross Margin of CASI Pharmaceuticals
12.8 Celgene Corporation
12.8.1 Company profile
12.8.2 Representative Sorafenib Product
12.8.3 Sorafenib Sales, Revenue, Price and Gross Margin of Celgene Corporation
12.9 Enzon Pharmaceuticals
12.9.1 Company profile
12.9.2 Representative Sorafenib Product
12.9.3 Sorafenib Sales, Revenue, Price and Gross Margin of Enzon Pharmaceuticals
12.10 Five Prime Therapeutics
12.10.1 Company profile
12.10.2 Representative Sorafenib Product
12.10.3 Sorafenib Sales, Revenue, Price and Gross Margin of Five Prime Therapeutics
12.11 Fujifilm Kyowa Kirin Biologics
12.11.1 Company profile
12.11.2 Representative Sorafenib Product
12.11.3 Sorafenib Sales, Revenue, Price and Gross Margin of Fujifilm Kyowa Kirin Biologics
12.12 Genentech
12.12.1 Company profile
12.12.2 Representative Sorafenib Product
12.12.3 Sorafenib Sales, Revenue, Price and Gross Margin of Genentech
12.13 Genexine
12.13.1 Company profile
12.13.2 Representative Sorafenib Product
12.13.3 Sorafenib Sales, Revenue, Price and Gross Margin of Genexine
12.14 Hetero Drugs
12.14.1 Company profile
12.14.2 Representative Sorafenib Product
12.14.3 Sorafenib Sales, Revenue, Price and Gross Margin of Hetero Drugs
12.15 ImClone Systems
12.15.1 Company profile
12.15.2 Representative Sorafenib Product
12.15.3 Sorafenib Sales, Revenue, Price and Gross Margin of ImClone Systems
12.16 Intas Pharmaceuticals
12.17 Levolta Pharmaceuticals
12.18 Mabtech
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SORAFENIB
13.1 Industry Chain of Sorafenib
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF SORAFENIB
14.1 Cost Structure Analysis of Sorafenib
14.2 Raw Materials Cost Analysis of Sorafenib
14.3 Labor Cost Analysis of Sorafenib
14.4 Manufacturing Expenses Analysis of Sorafenib
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Sorafenib in This Report
1.2 Commercial Types of Sorafenib
1.2.1 Capsule
1.2.2 Tablet
1.3 Downstream Application of Sorafenib
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Online Pharmac
1.4 Development History of Sorafenib
1.5 Market Status and Trend of Sorafenib 2013-2023
1.5.1 Global Sorafenib Market Status and Trend 2013-2023
1.5.2 Regional Sorafenib Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Sorafenib 2013-2017
2.2 Sales Market of Sorafenib by Regions
2.2.1 Sales Volume of Sorafenib by Regions
2.2.2 Sales Value of Sorafenib by Regions
2.3 Production Market of Sorafenib by Regions
2.4 Global Market Forecast of Sorafenib 2018-2023
2.4.1 Global Market Forecast of Sorafenib 2018-2023
2.4.2 Market Forecast of Sorafenib by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Sorafenib by Types
3.2 Sales Value of Sorafenib by Types
3.3 Market Forecast of Sorafenib by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Sorafenib by Downstream Industry
4.2 Global Market Forecast of Sorafenib by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Sorafenib Market Status by Countries
5.1.1 North America Sorafenib Sales by Countries (2013-2017)
5.1.2 North America Sorafenib Revenue by Countries (2013-2017)
5.1.3 United States Sorafenib Market Status (2013-2017)
5.1.4 Canada Sorafenib Market Status (2013-2017)
5.1.5 Mexico Sorafenib Market Status (2013-2017)
5.2 North America Sorafenib Market Status by Manufacturers
5.3 North America Sorafenib Market Status by Type (2013-2017)
5.3.1 North America Sorafenib Sales by Type (2013-2017)
5.3.2 North America Sorafenib Revenue by Type (2013-2017)
5.4 North America Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Sorafenib Market Status by Countries
6.1.1 Europe Sorafenib Sales by Countries (2013-2017)
6.1.2 Europe Sorafenib Revenue by Countries (2013-2017)
6.1.3 Germany Sorafenib Market Status (2013-2017)
6.1.4 UK Sorafenib Market Status (2013-2017)
6.1.5 France Sorafenib Market Status (2013-2017)
6.1.6 Italy Sorafenib Market Status (2013-2017)
6.1.7 Russia Sorafenib Market Status (2013-2017)
6.1.8 Spain Sorafenib Market Status (2013-2017)
6.1.9 Benelux Sorafenib Market Status (2013-2017)
6.2 Europe Sorafenib Market Status by Manufacturers
6.3 Europe Sorafenib Market Status by Type (2013-2017)
6.3.1 Europe Sorafenib Sales by Type (2013-2017)
6.3.2 Europe Sorafenib Revenue by Type (2013-2017)
6.4 Europe Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Sorafenib Market Status by Countries
7.1.1 Asia Pacific Sorafenib Sales by Countries (2013-2017)
7.1.2 Asia Pacific Sorafenib Revenue by Countries (2013-2017)
7.1.3 China Sorafenib Market Status (2013-2017)
7.1.4 Japan Sorafenib Market Status (2013-2017)
7.1.5 India Sorafenib Market Status (2013-2017)
7.1.6 Southeast Asia Sorafenib Market Status (2013-2017)
7.1.7 Australia Sorafenib Market Status (2013-2017)
7.2 Asia Pacific Sorafenib Market Status by Manufacturers
7.3 Asia Pacific Sorafenib Market Status by Type (2013-2017)
7.3.1 Asia Pacific Sorafenib Sales by Type (2013-2017)
7.3.2 Asia Pacific Sorafenib Revenue by Type (2013-2017)
7.4 Asia Pacific Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Sorafenib Market Status by Countries
8.1.1 Latin America Sorafenib Sales by Countries (2013-2017)
8.1.2 Latin America Sorafenib Revenue by Countries (2013-2017)
8.1.3 Brazil Sorafenib Market Status (2013-2017)
8.1.4 Argentina Sorafenib Market Status (2013-2017)
8.1.5 Colombia Sorafenib Market Status (2013-2017)
8.2 Latin America Sorafenib Market Status by Manufacturers
8.3 Latin America Sorafenib Market Status by Type (2013-2017)
8.3.1 Latin America Sorafenib Sales by Type (2013-2017)
8.3.2 Latin America Sorafenib Revenue by Type (2013-2017)
8.4 Latin America Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Sorafenib Market Status by Countries
9.1.1 Middle East and Africa Sorafenib Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Sorafenib Revenue by Countries (2013-2017)
9.1.3 Middle East Sorafenib Market Status (2013-2017)
9.1.4 Africa Sorafenib Market Status (2013-2017)
9.2 Middle East and Africa Sorafenib Market Status by Manufacturers
9.3 Middle East and Africa Sorafenib Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Sorafenib Sales by Type (2013-2017)
9.3.2 Middle East and Africa Sorafenib Revenue by Type (2013-2017)
9.4 Middle East and Africa Sorafenib Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF SORAFENIB
10.1 Global Economy Situation and Trend Overview
10.2 Sorafenib Downstream Industry Situation and Trend Overview
CHAPTER 11 SORAFENIB MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Sorafenib by Major Manufacturers
11.2 Production Value of Sorafenib by Major Manufacturers
11.3 Basic Information of Sorafenib by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Sorafenib Major Manufacturer
11.3.2 Employees and Revenue Level of Sorafenib Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 SORAFENIB MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer
12.1.1 Company profile
12.1.2 Representative Sorafenib Product
12.1.3 Sorafenib Sales, Revenue, Price and Gross Margin of Pfizer
12.2 Allergan
12.2.1 Company profile
12.2.2 Representative Sorafenib Product
12.2.3 Sorafenib Sales, Revenue, Price and Gross Margin of Allergan
12.3 Alnylam Pharmaceuticals
12.3.1 Company profile
12.3.2 Representative Sorafenib Product
12.3.3 Sorafenib Sales, Revenue, Price and Gross Margin of Alnylam Pharmaceuticals
12.4 Acceleron Pharma
12.4.1 Company profile
12.4.2 Representative Sorafenib Product
12.4.3 Sorafenib Sales, Revenue, Price and Gross Margin of Acceleron Pharma
12.5 Biocon
12.5.1 Company profile
12.5.2 Representative Sorafenib Product
12.5.3 Sorafenib Sales, Revenue, Price and Gross Margin of Biocon
12.6 Bionomics
12.6.1 Company profile
12.6.2 Representative Sorafenib Product
12.6.3 Sorafenib Sales, Revenue, Price and Gross Margin of Bionomics
12.7 CASI Pharmaceuticals
12.7.1 Company profile
12.7.2 Representative Sorafenib Product
12.7.3 Sorafenib Sales, Revenue, Price and Gross Margin of CASI Pharmaceuticals
12.8 Celgene Corporation
12.8.1 Company profile
12.8.2 Representative Sorafenib Product
12.8.3 Sorafenib Sales, Revenue, Price and Gross Margin of Celgene Corporation
12.9 Enzon Pharmaceuticals
12.9.1 Company profile
12.9.2 Representative Sorafenib Product
12.9.3 Sorafenib Sales, Revenue, Price and Gross Margin of Enzon Pharmaceuticals
12.10 Five Prime Therapeutics
12.10.1 Company profile
12.10.2 Representative Sorafenib Product
12.10.3 Sorafenib Sales, Revenue, Price and Gross Margin of Five Prime Therapeutics
12.11 Fujifilm Kyowa Kirin Biologics
12.11.1 Company profile
12.11.2 Representative Sorafenib Product
12.11.3 Sorafenib Sales, Revenue, Price and Gross Margin of Fujifilm Kyowa Kirin Biologics
12.12 Genentech
12.12.1 Company profile
12.12.2 Representative Sorafenib Product
12.12.3 Sorafenib Sales, Revenue, Price and Gross Margin of Genentech
12.13 Genexine
12.13.1 Company profile
12.13.2 Representative Sorafenib Product
12.13.3 Sorafenib Sales, Revenue, Price and Gross Margin of Genexine
12.14 Hetero Drugs
12.14.1 Company profile
12.14.2 Representative Sorafenib Product
12.14.3 Sorafenib Sales, Revenue, Price and Gross Margin of Hetero Drugs
12.15 ImClone Systems
12.15.1 Company profile
12.15.2 Representative Sorafenib Product
12.15.3 Sorafenib Sales, Revenue, Price and Gross Margin of ImClone Systems
12.16 Intas Pharmaceuticals
12.17 Levolta Pharmaceuticals
12.18 Mabtech
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SORAFENIB
13.1 Industry Chain of Sorafenib
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF SORAFENIB
14.1 Cost Structure Analysis of Sorafenib
14.2 Raw Materials Cost Analysis of Sorafenib
14.3 Labor Cost Analysis of Sorafenib
14.4 Manufacturing Expenses Analysis of Sorafenib
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
